These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2641004)

  • 21. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The discriminative stimulus properties of naloxone during dissociative learning in a Y maze in morphine-dependent rats].
    Bespalov AIu; Medvedev IO; Dravolina OA; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):96-105. PubMed ID: 10330710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidural morphine and naltrexone: withdrawal syndrome].
    Aguilar JL; Blanco D; Montes A; Llorente C; Vidal F
    Rev Esp Anestesiol Reanim; 1991; 38(2):127-8. PubMed ID: 1876736
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe opioid withdrawal due to misuse of new combined morphine and naltrexone product (Embeda).
    Jang DH; Rohe JC; Hoffman RS; Nelson LS
    Ann Emerg Med; 2010 Mar; 55(3):303-4. PubMed ID: 20171465
    [No Abstract]   [Full Text] [Related]  

  • 25. Naloxone-precipitated acute opioid withdrawal syndrome after epidural morphine.
    Sun HL
    Anesth Analg; 1998 Mar; 86(3):544-5. PubMed ID: 9495411
    [No Abstract]   [Full Text] [Related]  

  • 26. Unusual opioid withdrawal syndrome. A case-report.
    Kumor KM; Grochow LB; Hausheer F
    Lancet; 1987 Mar; 1(8535):720-1. PubMed ID: 2436013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiate withdrawal syndrome following intrathecal administration of morphine.
    Tung AS; Tenicela R; Winter PM
    Anesthesiology; 1980 Oct; 53(4):340. PubMed ID: 6893528
    [No Abstract]   [Full Text] [Related]  

  • 28. High-dose epidural morphine in a terminally ill patient.
    Woods WA; Cohen SE
    Anesthesiology; 1982 Apr; 56(4):311-2. PubMed ID: 6175252
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of the withdrawal syndrome in an opioid-dependent one-year-old child with decreasing pain.
    Rogers AG
    J Pain Symptom Manage; 1991 Apr; 6(3):129. PubMed ID: 2016557
    [No Abstract]   [Full Text] [Related]  

  • 30. Uncontrolled naloxone treatment.
    Dirksen R; Wood GJ; Nijhuis GM
    Lancet; 1981 Jun; 1(8232):1262-3. PubMed ID: 6112588
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma naloxone levels in the newborn after intravenous and intramuscular administration [proceedings].
    Brice JE; Moreland TA; Parija AC; Walker CH
    Br J Clin Pharmacol; 1979 Oct; 8(4):412P-413P. PubMed ID: 508546
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral naloxone in opioid-associated constipation.
    Robinson BA; Johansson L; Shaw J
    Lancet; 1991 Aug; 338(8766):581-2. PubMed ID: 1678844
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral naloxone in opioid-associated constipation.
    Sykes NP
    Lancet; 1991 Jun; 337(8755):1475. PubMed ID: 1675336
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: dangerous sequence of morphine, metoclopramide and naloxone.
    Cameron AG
    Med J Aust; 1975 Nov; 2(20):779. PubMed ID: 1214692
    [No Abstract]   [Full Text] [Related]  

  • 35. Accuracy in morphine administration.
    Knight J
    Br J Anaesth; 1979 Sep; 51(9):909-10. PubMed ID: 508498
    [No Abstract]   [Full Text] [Related]  

  • 36. Naloxone: a safe and effective drug.
    Grufferman S; Rose R
    Ann Emerg Med; 1988 Jul; 17(7):764. PubMed ID: 3382087
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dangerous injections].
    ZFA (Stuttgart); 1979 Mar; 55(7):452. PubMed ID: 425662
    [No Abstract]   [Full Text] [Related]  

  • 38. Intralingual naloxone injections.
    Wasserberger J; Ordog GJ; Kolodny M
    Ann Emerg Med; 1988 Aug; 17(8):874-5. PubMed ID: 3395004
    [No Abstract]   [Full Text] [Related]  

  • 39. Time course of repeated naloxone challenge after single morphine doses in humans.
    Heishman SJ; Stitzer ML
    NIDA Res Monogr; 1989; 95():385-6. PubMed ID: 2641004
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute opioid physical dependence in humans: maximum morphine-naloxone interval.
    Kirby KC; Stitzer ML; Heishman SJ
    NIDA Res Monogr; 1989; 95():393-4. PubMed ID: 2641007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.